The content is available as a PDF (396.7 KB).
Disclosures
None.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
. 2021 Jul 22;28(Suppl 3):560–561. doi: 10.1245/s10434-021-10423-1
ASO Visual Abstract: Surgical Management of Axilla Following Neoadjuvant Endocrine Therapy
Brenna M Murphy
1, Tanya L Hoskin
2, Amy C Degnim
3, Judy C Boughey
3, Tina J Hieken
3,✉
Brenna M Murphy, BS
1Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, MN USA
Find articles by Brenna M Murphy
Tanya L Hoskin, MS
2Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN USA
Find articles by Tanya L Hoskin
Amy C Degnim, MD
3Division of Breast and Melanoma Surgical Oncology, Department of Surgery, Mayo Clinic, Rochester, MN USA
Find articles by Amy C Degnim
Judy C Boughey, MD
3Division of Breast and Melanoma Surgical Oncology, Department of Surgery, Mayo Clinic, Rochester, MN USA
Find articles by Judy C Boughey
Tina J Hieken, MD
3Division of Breast and Melanoma Surgical Oncology, Department of Surgery, Mayo Clinic, Rochester, MN USA
Find articles by Tina J Hieken
1Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, MN USA
2Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN USA
3Division of Breast and Melanoma Surgical Oncology, Department of Surgery, Mayo Clinic, Rochester, MN USA
✉
Corresponding author.
Issue date 2021.
© Society of Surgical Oncology 2021
This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
PMCID: PMC8298042 PMID: 32468346